14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
As we have all witnessed, the COVID-19 situation remains incredibly fluid and presents unique challe...
Read More >
First, the good news: The Equal Employment Opportunity Commission (EEOC) has provided notice that it...
Read More >
Watch this two-minute video tip from Nilan Johnson Lewis litigator, Brandie Morgenroth, who discusse...
Read More >
Many jurisdictions have allowed construction activities to continue through the COVID-19 pandemic. B...
Read More >
A combination of New Jersey court decisions and legislative actions have expanded and clarified New ...
Read More >
The FAA has begun the process of amending its regulations to require that flight attendants at U.S. ...
Read More >